Nk-1 receptor antagonists for the treatment of cancer

Details Nk-1 receptor antagonists for the treatment of cancer Nk-1 receptor antagonists for the treatment of cancer

A - Human Necessities

61

K

A61K 31/435 (2006.01) A61K 31/439 (2006.01) A61K 31/445 (2006.01) A61K 31/4458 (2006.01)

Patent

CA 2189501

The present invention relates to the use of certain NK-1 receptor antagonists (e.g., substance P receptor antagonists) to treat cancer patients, particularly cancer patients afflicted with a small cell lung carcinoma, APUDoma, astrocytoma, neuroendocrine tumor or extrapulmonary small cell carcinoma.

Affiliated with

Also associated with

Rating

Nk-1 receptor antagonists for the treatment of cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nk-1 receptor antagonists for the treatment of cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nk-1 receptor antagonists for the treatment of cancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1515286